Tag Archives: Novartis

Novartis has aborted its latest patent filing at the European Patent Office. (Keystone / Georgios Kefalas) Swiss pharmaceutical giant Novartis has backed down in a patent dispute over the leukaemia therapy Kymriah following opposition from NGOs. The Swiss NGO Public Eye is claiming victory in the European Patent Officeexternal link battle, but Novartis says the patent in question was only one of several it has in place on the (CAR)-T cell therapy treatment it had...

Switzerland is the only country among the 47 members of the Council of Europe which does not have a law governing political party financing. (© Keystone / Gaetan Bally) Switzerland’s biggest firms – mainly banks, pharmaceutical firms and insurance companies – donate at least CHF5 million ($5 million) a year to political parties and candidates, a survey has revealed. The poll of 140 companies by Swiss public radio RTS, published on Tuesdayexternal link, found that one...

Novartis imports some 120 million packs of medicines into the UK each year. - Click to enlarge Swiss pharmaceuticals giant Novartis says a no-deal Brexit could hurt patients and that it is stockpiling medicines in the UK to help ensure continuity of supply. In a press releaseexternal link on Friday, it said that after the British parliament’s rejection of Prime Minister Theresa May’s Brexit deal, “the risk of UK...

Novartis currently employs 13,000 people across Switzerland The pharmaceutical giant Novartis will cut about 2,200 jobs in Switzerland over the next four years. Nearly 1,500 jobs are affected in production and about 700 in services. This restructuring is part of the manufacturing strategy launched in 2015 to adapt the industrial base to a reduced product portfolio, announced Novartis on Tuesdayexternal link. It...

The transaction underpins Novartis’s strategy of achieving sustainable and profitable growth in the US in the long term. Swiss pharmaceutical company Novartis announced the divestment of its dermatology and generic tablet portfolios of Sandoz US to India’s Aurobindo Pharma for a $900 million (CHF870 million) cash payment. A possible performance-related payment of $100 million could be added to the purchase price, the...

Novartis admitted that it had signed a one-year contract with the company of Trump’s private lawyer, Michael Cohen. (Keystone) The Office of the Attorney General of Switzerland (OAG) announced on Wednesday that it will not bring proceedings against Novartis in connection with the payments the Swiss pharmaceutical company made to Donald Trump’s personal lawyer. The OAGexternal link had received a criminal complaint...

Greece's government says it has evidence that senior politicians from the previous administration were involved in a bribery case in which Swiss drugmaker Novartis is accused of making illegal payments to fix prices and increase market access (Keystone) - Click to enlarge Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States...

The so-called Schweizerhalle, a Novartis factory in Muttenz (© KEYSTONE / GEORGIOS KEFALAS) - Click to enlarge Greece’s parliament has linked ten prominent politicians to a bribery scandal involving Swiss drug-maker Novartis. The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based Novartisexternal link over nearly a decade...

Investec Switzerland. Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. © Lucaderoma | Dreamstime.com Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday in a statement. Sales will show little change. Novartis is depending on...

Investec Switzerland. Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. © Lucaderoma | Dreamstime.com Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday...